Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Biolase Inc. logo

Biolase Inc.

Sector: Healthcare   

Industry: Medical Instruments & Supplies

0.14
 
USD
  
-0.01
  
(-4.09%)
Optionable: No  Market Cap: 5 M  90-day average vol: 5,665,424

Previous close: 0.1418  Open: 0.1465  Bid: 0.1363  Ask: 0.14
52 week range    
0.13   
   47.10
Peers   
ALGN / 
XRAY / 
Last updated: Tuesday 16th April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ALGN

40 B53.5500.22

PDEX

0 B22.522.2

XRAY

0.008412 B28.152.12
Financials

BIOL Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AllowancesForConstruction17 M
Amortization of intangibles-117000.0-69000.0-63000.0-51000.0
Basic EPS from continuing operations-19.25-14.0
Basic EPS total-8.75-11.25-8.75-7.25-7.0-26.25-19.25-14.0-4.16
Basic weighted shares outstanding1 M2 M2 M2 M3 M823520.0928040.02 M6 M7 M
Cost of sales-35 M-29 M-33 M-32 M-32 M-29 M24 M17 M23 M-33 M
Depreciation-484000.0-627000.0-817000.0-997000.0-1 M-900000.0-1000000.0-500000.0-400000.0-500000.0
DepreciationAndAmortization-484000.0-627000.0-817000.0-997000.0-1 M-900000.0-1000000.0-500000.0-400000.0-500000.0
Diluted EPS total-8.75-11.25-8.75-7.25-7.0-26.25-19.25-14.0-2.75-4.16
Diluted normalized net income/share-19.25-14.0-2.75
Diluted weighted shares outstanding1 M2 M2 M2 M3 M823520.0928040.02 M6 M7 M
Earnings from equity interest193032.0
EarningsFromEquityInterestNetOfTax193032.0
Fees197000.0
GainOnSaleOfPPE-505000.0-1 M
GeneralAndAdministrativeExpense9 M15 M10 M10 M10 M12 M11 M10 M11 M12 M
Gross operating profit22 M18 M16 M20 M15 M17 M14 M-17 M17 M16 M
Income before tax-12 M-19 M-20 M-15 M-17 M-21 M-18 M-52 M-16 M-29 M
Income taxes-164000.0112000.0178000.0151000.0-582000.063000.0-44000.0128000.065000.0109000.0
InsuranceAndClaims-217000.0
Interest income-600000.0-458000.074000.074000.042000.0-510000.0-2 M2 M-2 M-3 M
InterestExpenseNonOperating-599000.0-457000.0
InterestExpenseOperating2 M
MiscOtherSpecialCharges1 M861000.0976000.0830000.01 M4 M3 M
Net income from total operations-11 M-19 M-20 M-18 M-21 M-22 M-18 M-52 M-16 M-28 M
NetIncomeCommonStockholders-11 M-19 M-20 M-18 M-21 M-22 M-18 M-52 M-16 M-28 M
NetIncomeContinuousOperations-11 M-19 M-20 M-18 M-21 M-22 M-18 M-52 M-16 M-28 M
NetNonOperatingInterestIncomeExpense-600000.0-458000.074000.074000.042000.0-510000.0-2 M2 M-2 M-3 M
NonRecurringOperationExpense-250000.0-1 M-1 M2 M315000.0
Operating income-11 M-18 M-20 M-15 M-22 M-18 M-16 M-59 M-16 M-25 M
Operating income before depreciation (EBITDA)-11 M-18 M-19 M-14 M-16 M-20 M-17 M-51 M-15 M-27 M
OperatingExpense-33 M-36 M-36 M-35 M-33 M-38 M30 M42 M33 M-41 M
Other income net-1 M-1 M-976000.02 M505000.01 M-4 M-3 M
OtherGandA9 M15 M10 M10 M10 M12 M11 M10 M11 M12 M
OtherImpairmentOfCapitalAssets2 M-500000.0-1 M
OtherOperatingExpenses438000.0307000.0-370000.0315000.0
PromotionAndAdvertising-1 M-543000.0-929000.0-351000.0-300000.0-600000.0-500000.017 M-1 M-1 M
RentAndLandingFees9 M15 M10 M10 M10 M12 M-800000.0-700000.0-900000.012 M
Research & development expense4 M5 M7 M8 M6 M5 M5 M4 M6 M7 M
ResearchExpense4 M5 M7 M8 M6 M5 M5 M4 M6 M7 M
Revenue per share-314000.0-269000.0-63000.0-51000.0
SalariesAndWages-2 M-1 M-3 M-3 M-2 M-3 M-3 M-3 M-2 M-2 M
Selling Gen & administrative expense28 M31 M29 M27 M26 M30 M25 M38 M27 M34 M
SellingAndMarketingExpense19 M16 M19 M17 M17 M18 M14 M29 M15 M22 M
SellingExpense19 M16 M19 M17 M17 M18 M14 M11 M15 M22 M
Special income/charges250000.01 M1 M-1 M-315000.0
Total Income available for interest expense (EBIT)-12 M-19 M-20 M-15 M-17 M-21 M-18 M-52 M-16 M-29 M
Total common shares outstanding300756.0465222.0465820.0540567.0818757.0845046.01 M6 M6 M26,327 M
Total net income-11 M-19 M-20 M-18 M-21 M-22 M-18 M-52 M-16 M-28 M
Total ordinary shares2 M2 M2 M2 M2 M2 M2 M2 M2 M2 M
Total revenues56 M48 M48 M52 M47 M46 M38 M23 M39 M48 M
TotalExpenses-67 M-66 M-68 M-67 M-65 M-67 M53 M59 M56 M-74 M
TotalRevenue56 M48 M48 M52 M47 M46 M38 M23 M39 M48 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University